Malnutrition, maintenance dose intensity and event-free survival in children with acute lymphoblastic leukemia
Tóm tắt
The role of malnutrition in event-free survival (relapse or death) in children with acute lymphoblastic leukemia (ALL), admitted at the Rio Blanco Regional Hospital, is assessed. The files of children under 12 years of age with ALL, diagnosed and treated from 1990 to 1997 were analyzed. According to the score z (≤1.28) of the weight/age, height/age, and weight/height anthropometric indicators, children were classified into two groups: nourished and malnourished children. Event-free survival curves were made and the impact that other risk factors had on prognosis was analyzed. The association of age, white blood cells and nutritional status, in the presence of an unfavorable event was estimated, using a multiple regression model. Twenty-three patients were studied, of which 12 suffered malnutrition. The mortality rate among the malnourished children was of 50% versus 9.1%, among the nourished children in the survival curve, and in the log rank test the weight versus age was of significant influence (p<0.04). The two most relevant risk factors for the presence of events were malnutrition and L2 type leukemia. In a multiple regression model, malnutrition was the only factor associated with the presence of events. Malnutrition was a risk factor for the presence of unfavorable events, being even more important than age and white blood cell count. Prospective studies that analyze the relationship of malnutrition and ALL, as well as the pharmacokynetics of antineoplastic agents in malnourished patients, are needed.
Tài liệu tham khảo
Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intnsive treatment regime in non-high-risk childhood acute lymphoblastic leukemia, results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14 (3): 911–8.
Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994;84(9):3122–33.
Rivera GK, Pui CH, Hancock ML, et al. Update of St. Jude XI for childhood acute lymphoblastic leukemia. Leukemia 1992;6 (Suppl 2):153–6.
Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia: 30 yenars' experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289–95.
Simone JV, Verzosa MS, Rudy JA. Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer 1975;36:2009–108.
Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignament for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14 (1):18–24.
Miller DR, Leiken S, Albo D. Prognostic importance of morphology (FAB Classification) in childhood acute lymphoblastic leukemia. Br J Haematol 1981;48:199–206.
Ribeiro RC, Pui CH. Prognostic factors in childhood acute lymphoblastic leukemia. Hematol Pathol 1993;7 (3): 121–42.
Ávila CA, Chávez VA, Shamah LT, Madrigal FH. La desnutrición infantil en el medio rural mexicano. Análisis de las encuestas nacionales de alimentación. Salud Pública Mex 19;1993:35:658–66.
Gómez-Almaguer D, Ruiz Argüelles G, Ponce de León S. Nutritional status and socio-economic conditions as prognostic factors in the outcome of therapy in chidlhood acute lymphoblastic leukemia. Int J Cancer 1998;11 (Suppl): 52–55.
Reilly JJ, Odame I, McColl JH, McAllister RJ, Gibson BES, Wharton BA. Does Weight for Height have Prognostic significance in children with acute lymphoblas-tic leukemia? Am J Pediatr Hematol Oncol 1994;16 (3): 225–30.
Marín-López A, Lobato-Mendizabal E, Ruiz-Argüelles G. La desnutrición es un factor pronóstico adverso en la respuesta al tratamiento y supervivencia de pacientes con leucemia aguda linfoblástica de riesgo habitual. Gac Med Mex 1991;127 (2):125–165.
Lobato-Mendizábal ME, Ruiz-Argüelles GJ. Efecto del tratamiento quimioterápico sobre el estado nutricional y su repercusión en la respuesta terapéutica de pacientes con LLA de riesgo estándar. Sangre 1990;35 (3):189–95.
Lobato-Mendizábal E, Ruiz-Argüelles GJ, Marín-López A. Leukaemia and nutrition, I. Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res 1989;13:899–906.
Verduzco-Rodríguez L, Ibarra-Colado J. Tratamiento de leucemia aguda linfoblástica en niños de escasos recursos en un hospital comunitario del estado de Veracruz. Rev Invest Clin 1998; 50:477–81.
Chandy M. Childhood acuty lymphoblastic leukemia in India: an approach to management in a three-tier society. Med Pediat Oncol 1995;25:197–203.
Norma Oficial Mexicana NOM-008-SSA2-1993. Control de la nutrición, crecimiento y desarrollo del niño y del adolescente.
Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994;71:304–10.
Macharia WM. Comparison of prognostic determinants in childhood acute lymphoblastic leukaemia in negroid and caucasian populations. East African Med J 1996;73: 638–42.
Mihraniana MH, Wang YM, Daly JM. Effects of nutritional depletion and repletion on plasma metotrexate pharmacokinetics. Cancer 1984; 54(10):2268–71.
Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinetic 1994;26 (4):292–307.
Rajeswari R, Shetty PA, Gothoskar BP, Akolkar PN, Gokjihale SV. Pharmacokinetics of metotrexate in adult Indian patients and its relationship to nutritional status. Cancer Treat Rep 1984;68 (5):727–32.
Bidlack WR, Brown RC, Mohan C. Nutritional parameters that alter hepatic drug metabolism, conjugation and toxicity. Fed Proc 1986;45(2):142–8.
Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 1996; 31 (1):47–64.